LARIMAR THERAPEUTICS INC (LRMR)
US5171251003 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -45.08M | -36.95M | -35.36M | -50.64M | -42.48M | |||
| Depreciation Amortization | 311.00K | 311.00K | 320.00K | 330.00K | 160.00K | |||
| Change In Working Capital | 2.35M | -2.59M | 1.62M | 2.75M | -2.04M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 6.10M | 5.77M | 5.85M | 5.46M | 2.17M | |||
| OPERATING CASH FLOW | -36.32M | -33.46M | -27.57M | -42.11M | -42.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -164.00K | -100.00K | -330.00K | -60.00K | |||
| Other Investing Activity | -127.10M | 33.52M | -90.86M | 24.50M | 17.15M | |||
| INVESTING CASH FLOW | -127.26M | 33.35M | -90.96M | 24.17M | 17.09M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 30.00K | 75.26M | 19.89M | 75.59M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 18.00M | |||
| FINANCING CASH FLOW | N/A | 30.00K | 75.26M | 19.89M | 93.59M | |||
| CHANGE IN CASH | -1.40M | -76.00K | -43.27M | 1.95M | 68.48M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -36.32M | -33.46M | -27.57M | -42.11M | -42.20M | |||
| Capital Expenditure | N/A | -164.00K | -100.00K | -330.00K | -60.00K | |||
| FREE CASH FLOW | -36.48M | -33.62M | -27.67M | -42.44M | -42.26M | |||
All data in USD